Joris Delanghe

18.5k total citations
446 papers, 13.2k citations indexed

About

Joris Delanghe is a scholar working on Molecular Biology, Nephrology and Physiology. According to data from OpenAlex, Joris Delanghe has authored 446 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 77 papers in Nephrology and 75 papers in Physiology. Recurrent topics in Joris Delanghe's work include Hemoglobin structure and function (54 papers), Chronic Kidney Disease and Diabetes (46 papers) and Neonatal Health and Biochemistry (37 papers). Joris Delanghe is often cited by papers focused on Hemoglobin structure and function (54 papers), Chronic Kidney Disease and Diabetes (46 papers) and Neonatal Health and Biochemistry (37 papers). Joris Delanghe collaborates with scholars based in Belgium, United States and Netherlands. Joris Delanghe's co-authors include Marijn M. Speeckaert, Marc De Buyzere, Reinhart Speeckaert, Michel R. Langlois, Youri Taes, Hans Van Vlierberghe, Michel R. Langlois, Nico Callewaert, Evi Debruyne and Guangming Huang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Joris Delanghe

435 papers receiving 12.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joris Delanghe Belgium 64 2.8k 2.0k 1.9k 1.6k 1.3k 446 13.2k
Anders Larsson Sweden 63 3.1k 1.1× 2.1k 1.0× 1.8k 1.0× 3.1k 1.9× 1.0k 0.8× 592 16.2k
Hiroshi Watanabe Japan 52 4.4k 1.6× 981 0.5× 1.5k 0.8× 1.1k 0.7× 620 0.5× 548 12.4k
Moshe Levi United States 59 5.7k 2.0× 1.6k 0.8× 2.0k 1.1× 4.1k 2.6× 699 0.5× 193 14.7k
Merlin C. Thomas Australia 69 4.2k 1.5× 1.7k 0.9× 1.8k 1.0× 4.1k 2.6× 651 0.5× 351 18.8k
Takuya Fujita Japan 55 4.0k 1.4× 2.0k 1.0× 2.5k 1.3× 427 0.3× 772 0.6× 360 14.5k
Niels Olsen Saraiva Câmara Brazil 57 4.7k 1.7× 1.7k 0.9× 1.8k 1.0× 1.8k 1.2× 499 0.4× 437 13.6k
Henrik E. Poulsen Denmark 69 5.1k 1.8× 2.4k 1.2× 1.8k 1.0× 417 0.3× 984 0.8× 446 19.6k
Maria Benedetta Donati Italy 68 2.8k 1.0× 1.9k 0.9× 1.6k 0.9× 483 0.3× 516 0.4× 573 17.3k
Dorine W. Swinkels Netherlands 67 2.5k 0.9× 1.1k 0.5× 1.4k 0.7× 618 0.4× 642 0.5× 298 15.8k
Anders Grubb Sweden 74 4.5k 1.6× 1.2k 0.6× 3.2k 1.7× 7.2k 4.6× 1.3k 1.0× 340 19.9k

Countries citing papers authored by Joris Delanghe

Since Specialization
Citations

This map shows the geographic impact of Joris Delanghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris Delanghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris Delanghe more than expected).

Fields of papers citing papers by Joris Delanghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris Delanghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris Delanghe. The network helps show where Joris Delanghe may publish in the future.

Co-authorship network of co-authors of Joris Delanghe

This figure shows the co-authorship network connecting the top 25 collaborators of Joris Delanghe. A scholar is included among the top collaborators of Joris Delanghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris Delanghe. Joris Delanghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lapauw, Bruno, et al.. (2024). Use of labile HbA1c as a screening tool to minimize clinical misinterpration of HbA1c. Clinical Chemistry and Laboratory Medicine (CCLM). 63(4). 831–840.
2.
Delrue, Charlotte, Michele F. Eisenga, Joris Delanghe, & Marijn M. Speeckaert. (2024). Personalized Antifibrotic Therapy in CKD Progression. Journal of Personalized Medicine. 14(12). 1141–1141. 2 indexed citations
3.
Delrue, Charlotte, Reinhart Speeckaert, Joris Delanghe, & Marijn M. Speeckaert. (2023). Vitamin D Deficiency: An Underestimated Factor in Sepsis?. International Journal of Molecular Sciences. 24(3). 2924–2924. 17 indexed citations
4.
Speeckaert, Marijn M., Karel Claes, Phillip Blondeel, et al.. (2023). Enzymatic Deglycation of Damaged Skin by Means of Combined Treatment of Fructosamine-3-Kinase and Fructosyl-Amino Acid Oxidase. International Journal of Molecular Sciences. 24(10). 8981–8981. 2 indexed citations
5.
Bruyne, Sander De, Loes van Schie, Filip De Somer, et al.. (2021). A Potential Role for Fructosamine-3-Kinase in Cataract Treatment. International Journal of Molecular Sciences. 22(8). 3841–3841. 12 indexed citations
6.
Favresse, Julien & Joris Delanghe. (2021). High-resolution capillary electrophoresis for the determination of carbamylated albumin. Clinical Chemistry and Laboratory Medicine (CCLM). 0(0). 229–234. 1 indexed citations
7.
Speeckaert, Marijn M., Reinhart Speeckaert, & Joris Delanghe. (2020). Potential underlying mechanisms of cerebral venous thrombosis associated with COVID-19. Journal of Neuroradiology. 47(6). 473–474. 10 indexed citations
8.
Brochez, Liève, Reinhart Speeckaert, Dirk De Bacquer, Joris Delanghe, & Isabelle Hoorens. (2019). Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case–control study. The Journal of Dermatology. 46(3). 274–275. 2 indexed citations
9.
Flórez, María R., Marta Costas‐Rodríguez, Charlotte Grootaert, et al.. (2017). Natural Fe isotope fractionation in an intestinal Caco-2 cell line model. Journal of Analytical Atomic Spectrometry. 32(9). 1713–1720. 16 indexed citations
10.
Paepe, Dominique, et al.. (2015). Biological validation of feline serum cystatin C: The effect of breed, age and sex and establishment of a reference interval. The Veterinary Journal. 204(2). 168–173. 24 indexed citations
11.
Goessaert, An‐Sofie, et al.. (2015). Haptoglobin polymorphism : an explanation for global polyuria?. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
12.
Hollevoet, Kevin, Kristiaan Nackaerts, J. Thimpont, et al.. (2010). Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma. American Journal of Respiratory and Critical Care Medicine. 181(6). 620–625. 78 indexed citations
13.
Delanghe, Joris, Marc De Buyzere, Ernst Rietzschel, G De Backer, & Dirk De Bacquer. (2008). Variation in HDL cholesterol methodology and calibration may lead to erroneous cardiovascular risk estimation. Clinical Chemistry. 54(6). 6. 1 indexed citations
14.
Colpaert, Kirsten, et al.. (2007). Low creatine kinase activities in critically ill patients: A cohort study. Critical Care Medicine. 35(12). 153. 1 indexed citations
15.
Pynaert, Ilse, Joris Delanghe, Marleen Temmerman, & Stefaan De Henauw. (2007). Iron Intake in Relation to Diet and Iron Status of Young Adult Women. Annals of Nutrition and Metabolism. 51(2). 172–181. 27 indexed citations
16.
Depypere, Herman, Michel R. Langlois, Joris Delanghe, Marleen Temmerman, & Marc Dhont. (2006). Haptoglobin polymorphism in patients with preeclampsia. Clinical Chemistry and Laboratory Medicine (CCLM). 44(8). 924–8. 21 indexed citations
17.
Taes, Youri, Birgitte Wuyts, Johan R. Boelaert, An S. De Vriese, & Joris Delanghe. (2004). Prohepcidin accumulates in renal insufficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 42(4). 387–9. 78 indexed citations
18.
Delanghe, Joris, et al.. (2002). Caveats in carbohydrate-deficient transferrin determination - Response.. Clinical Chemistry. 48(1). 209–209.
19.
Aps, Johan, Joris Delanghe, & Luc Martens. (1999). SDS-PAGE of salivary proteins in Cystic Fibrosis: preliminary results.. Ghent University Academic Bibliography (Ghent University). 2 indexed citations
20.
Delanghe, Joris, et al.. (1996). Pseudohypertriglyceridemia due to benign glycerol kinase deficiency. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Larsson Breakdown of academic impact, for papers by Hiroshi Watanabe Breakdown of academic impact, for papers by Moshe Levi Breakdown of academic impact, for papers by Merlin C. Thomas Breakdown of academic impact, for papers by Takuya Fujita Breakdown of academic impact, for papers by Niels Olsen Saraiva Câmara Breakdown of academic impact, for papers by Henrik E. Poulsen Breakdown of academic impact, for papers by Maria Benedetta Donati Breakdown of academic impact, for papers by Dorine W. Swinkels Breakdown of academic impact, for papers by Anders Grubb
Rankless by CCL
2026